3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
4
Ovarian Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinosarcoma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma, Ovarian
1
Teratoma
1
Stomach Neoplasms
1
Stage IA Uterine Sarcoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Recurrence
1
Platinum-Refractory Fallopian Tube Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Interventions
Cyclophosphamide
9
Doxorubicin
8
Vincristine
6
Etoposide
6
Ifosfamide
5
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Cisplatin
3
Carboplatin
3
seclidemstat
2
Temozolomide
2
Tacrolimus
2
Neoadjuvant Therapy
2
Irinotecan
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
Brachytherapy
2
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
Taxes
×
Sarcoma
×
Clear all
NCT03275818
2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Completed
69 enrolled